Mark Soberman becomes president of ACCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Soberman, was elected as the 2017-2018 President of the Association of Community Cancer Centers during its annual meeting March 31.

A thoracic surgeon and thoracic oncologist, Soberman is the medical director, Oncology Service Line and chief physician executive, Monocacy Health Partners at Frederick Regional Health System.

Soberman has been an active member of ACCC, serving on the executive committee of the board of trustees and as President-Elect (2016-2017).

He is a reviewer for the Annals of Thoracic Surgery and an active member of numerous organizations, including the Society of Thoracic Surgeons, the Southern Thoracic Surgical Association, the General Thoracic Surgical Club, the American Association for Physician Leadership, the American College of Healthcare Executives, and the American Society of Clinical Oncology.

Previously, Soberman served as vice-chair of the Department of Surgery; director, Section of Thoracic Oncology; and director, Section of Thoracic Surgery at MedStar Washington Hospital Center. Soberman has held leadership positions as Director, Division of Thoracic S urgery at Georgetown University Hospital, and Director, Section of Thoracic Surgery at Sibley Memorial Hospital.

His academic appointments include clinical associate professor of surgery at Georgetown University School of Medicine and Clinical Assistant Professor of Surgery at George Washington University School of Medicine.

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login